International recognition for Mainz-based research on altermagnetism, a new concept in physics.

Every year, the high-profile academic journal "Science" names ten groundbreaking discoveries in a top list of scientific ...

Local AIDS experts are at odds with the United Nations Programme on HIV/AIDS (UNAIDS) over its claims that AIDS could be ...

In recent years, the investment landscape has seen a significant shift towards socially responsible investing strategies.

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Global leaders must urgently prioritise and work to provide access to new long-acting HIV prevention -- and potentially ...

The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of ...

So far, the FDA has approved the drug only for people who already have HIV that’s resistant to other treatments. But its ...

It’s all the more tragic because HIV drugs can keep people from catching the virus, and prevent those living with the virus from passing it on. If everyone who needed these drugs could access them, ...

The Global Fund to fight AIDS, TB and Malaria and the US President’s Emergency Plan for AIDS Relief (PEPFAR) recently announced a deal to get lenacapavir to 2 million people over the next three years.